Skip to content

Cobalt's Generic Boniva Barred in Roche IP Spat

By Megan Stride, Law360
Loeb & Loeb LLP and Mark Waddell are noted as counsel for Hoffmann-La Roche Inc. in the pharmaceutical company's successful bid for preliminary injunction barring Cobalt Pharmaceuticals Inc. from launching a generic version of the branded osteoporosis drug Boniva®.